One of the most important efforts in healthcare research over the next decade will be to integrate advances in biology, material sciences and chemical and bioengineering to create a revolutionary new generation of medical devices and drug delivery systems. Indeed, the main challenge facing researchers in these diverse fields may not be a lack of scientific progress, but rather a shortage of adequate interdisciplinary training.
A key area for research will involve tissue engineering, which generally involves combining the cells of mammals (including stem cells) with polymer-materials to create new tissues or organs. It is now estimated that nearly half a nation's healthcare costs can be attributed to tissue loss or organ failure. The ability to create new livers, spinal cords, hearts, kidneys and many other tissues or organ-based systems could radically decrease hospitalization time, relieve suffering, and prolong life.
The challenges here are, of course, huge. In particular, an appropriate source must be found for producing a large enough supply of differentiated cells quickly enough. Stem cells represent a potentially important potential source, but problems in controlling their differentiation and growth must first be overcome, as must rejection by the human immune system.
Another path to be pursued involves the development of micro-electrical mechanical systems (MEMS) that can be used in drug delivery. These microdevices would be made of silicon or other materials that can be loaded with drugs (or sensors) and covered with caps made of gold or other substances. An electrical signal to the implant would dissolve the gold cover to release the drug.
Such systems have the potential to deliver new kinds of drugs in complex regimens which might be useful for cancer chemotherapy, for example. They could also provide new means of localized drug delivery that might be useful in several areas, including delivery of multiple drugs. Finally, such systems might also create new opportunities for bio-sensing devices that could be placed on a computer chip.
New kinds of biomaterials for medical devices are also on the horizon. Currently, most biomaterials are off-the-shelf materials that were originally used in consumer applications. For example, the material in the artificial heart was originally used to make girdles for women. Some breast implant materials were originally used in mattress stuffing.
A potentially important area here is the development of materials that have a "shape memory." For example, a surgeon might place something like a string through a small endoscopic hole; in the presence of an appropriate stimulus (for example, temperature or light), it would then convert itself into an appropriately shaped medical device such as a stent, or a sheet to prevent adhesion. Another potential use for such materials might be self-tying sutures that could be employed in minimally invasive surgery.
New materials will also be necessary to overcome one of the main obstacles to successful gene therapy: the absence of appropriate delivery systems. While viruses are a highly efficient means, they pose safety risks. Likewise, the non-invasive delivery of complex molecules such as peptides or proteins remains a major challenge.
Currently such molecules are given by injection. But if scientists can develop better delivery systems or synthetic agents that are safer, cheaper and easier to manufacture, enormous opportunities will be created for complex drugs that could be given without injections.
New advances in engineering medicine may help in targeting drugs at specific cells, particularly cancer cells, which has been extremely difficult to do for several reasons. One challenge is to design micro or nano particles that can travel throughout the bloodstream without being absorbed by other cells along the way. If that can be accomplished, "magic bullets" to fight cancer, heart disease, and other disorders might someday be possible.
All of these looming changes will likely have an enormous impact on drug development and diagnostics.
However, developing and exploiting the full array of potential new disease-fighting weapons will require outstanding scientists and engineers, including those with interdisciplinary training.
Robert Langer is an institute professor at the Massachusetts Institute of Technology.
Copyright: Project Syndicate
Could Asia be on the verge of a new wave of nuclear proliferation? A look back at the early history of the North Atlantic Treaty Organization (NATO), which recently celebrated its 75th anniversary, illuminates some reasons for concern in the Indo-Pacific today. US Secretary of Defense Lloyd Austin recently described NATO as “the most powerful and successful alliance in history,” but the organization’s early years were not without challenges. At its inception, the signing of the North Atlantic Treaty marked a sea change in American strategic thinking. The United States had been intent on withdrawing from Europe in the years following
My wife and I spent the week in the interior of Taiwan where Shuyuan spent her childhood. In that town there is a street that functions as an open farmer’s market. Walk along that street, as Shuyuan did yesterday, and it is next to impossible to come home empty-handed. Some mangoes that looked vaguely like others we had seen around here ended up on our table. Shuyuan told how she had bought them from a little old farmer woman from the countryside who said the mangoes were from a very old tree she had on her property. The big surprise
The issue of China’s overcapacity has drawn greater global attention recently, with US Secretary of the Treasury Janet Yellen urging Beijing to address its excess production in key industries during her visit to China last week. Meanwhile in Brussels, European Commission President Ursula von der Leyen last week said that Europe must have a tough talk with China on its perceived overcapacity and unfair trade practices. The remarks by Yellen and Von der Leyen come as China’s economy is undergoing a painful transition. Beijing is trying to steer the world’s second-largest economy out of a COVID-19 slump, the property crisis and
Ursula K. le Guin in The Ones Who Walked Away from Omelas proposed a thought experiment of a utopian city whose existence depended on one child held captive in a dungeon. When taken to extremes, Le Guin suggests, utilitarian logic violates some of our deepest moral intuitions. Even the greatest social goods — peace, harmony and prosperity — are not worth the sacrifice of an innocent person. Former president Chen Shui-bian (陳水扁), since leaving office, has lived an odyssey that has brought him to lows like Le Guin’s dungeon. From late 2008 to 2015 he was imprisoned, much of this